Core Viewpoint - A federal class-action lawsuit has been filed against aTyr Pharma, Inc. following an 83% drop in its stock price after its lead drug candidate failed to meet primary endpoints in a Phase 3 trial [1][7]. Group 1: Lawsuit Details - The lawsuit, titled Munguia v. aTyr Pharma Inc., alleges that aTyr and its executives made false and misleading statements regarding the efficacy of its drug Efzofitimod, leading to inflated stock prices [2][5]. - The proposed class includes all investors who acquired aTyr common stock between January 16, 2025, and September 12, 2025 [3]. - The allegations center around aTyr's Phase 3 study, EFZO-FIT, which evaluated Efzofitimod in patients with pulmonary sarcoidosis [3]. Group 2: Company Statements and Market Reaction - Throughout the class period, aTyr executives expressed confidence in the study's design and the drug's potential to reduce steroid dependency [4]. - The lawsuit claims that while making optimistic statements, aTyr was concealing adverse facts about Efzofitimod's efficacy, which constitutes a violation of securities laws [5]. - The negative results from the EFZO-FIT study were disclosed on September 15, 2025, leading to a drastic decline in stock price from $6.03 to $1.02, a drop of 83.2% [6][7]. Group 3: Investigation and Market Opportunity - Hagens Berman is investigating whether aTyr misled investors regarding trial data and the drug's market potential, which was emphasized as a multi-billion-dollar opportunity [8]. - The firm is urging investors who suffered losses or have relevant information to come forward [9].

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Soleno (SLNO) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Soleno and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally recognized ...

NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder litigation firm, alerts investors that a securities class action lawsuit has been filed in the United States District Court for the District of Oregon against KinderCare Learning Companies, Inc. (“KinderCare” or the “Company”) (NYSE: KLC), certain of its former and current officers and/or directors, and underwriters (collectively, “Defendants”). The Class Action asserts claims under §§1 ...

NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder litigation firm, alerts investors that a securities class action lawsuit has been filed in the United States District Court for the District of Oregon against KinderCare Learning Companies, Inc. (“KinderCare” or the “Company”) (NYSE: KLC), certain of its former and current officers and/or directors, and underwriters (collectively, “Defendants”). The Class Action asserts claims under §§1 ...

SAN DIEGO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether Slide Insurance Holdings, Inc. (NASDAQ: SLDE) or any of its executive officers violated securities laws by misrepresenting or failing to disclose material information to investors. What is this all about?Shares of Slide Insurance have fallen over 25% since the Company’s June IPO. On September 30, a Manatee Research report alleged that Slide’s underwriting margins are driven by claim denials ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Agilon and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally recognize ...

NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the federal securities laws. If you invested in Simulations Plus, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/simulations-plus-inc-class-action-lawsuit. Why Is Simulations Plus being Investigated?Simulations Plus is a software company that develops tools for modeli ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Anika (ANIK) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Anika and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally recognized ...

Core Viewpoint - Simulations Plus, Inc. is under investigation for potential violations of federal securities laws following disappointing financial results and issues related to its acquisition of Pro-ficiency Holdings, Inc. [1][2][3] Company Overview - Simulations Plus is a software company focused on modeling and simulation tools for the pharmaceutical, biotechnology, and chemical industries [2] - The company acquired Pro-ficiency Holdings, Inc. in June 2024, aiming to double its total addressable market and enhance sales [2][3] Financial Performance and Issues - Simulations Plus reported challenges in integrating Pro-ficiency and acknowledged ineffective internal controls over financial reporting [3] - On June 11, 2025, the company announced disappointing preliminary financial results for Q3 2025, attributing the decline to market uncertainties, leading to a stock price drop of over 24% [4] - The company reported a $77.2 million charge related to prior acquisitions in its Q3 2025 financial results and dismissed its auditor Grant Thornton, citing unresolved matters regarding segment reporting and internal controls [5] Stock Market Reaction - Following the announcement of the impairment charge and auditor dismissal, Simulations Plus's stock fell nearly 26% from $17.47 to $12.97 per share [5]

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against BellRing Brands Inc. regarding possible violations of federal securities laws and unlawful business practices affecting stockholders [2]. Investigation Details - The law firm is reaching out to investors who purchased or acquired BellRing Brands shares and suffered losses, encouraging them to discuss their legal rights and options [1][3]. - The investigation follows a significant drop in BellRing Brands' stock price, which fell nearly 19% after the company announced that certain customers were optimizing their inventories, leading to a slowdown in sales growth to "low-single-digits" for the third quarter of 2025 [6]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm with expertise in representing individual and institutional investors in complex litigation across state and federal courts [4].